champaign 发表于 2025-3-25 04:13:49

http://reply.papertrans.cn/71/7036/703513/703513_21.png

爆炸 发表于 2025-3-25 08:54:02

http://reply.papertrans.cn/71/7036/703513/703513_22.png

多节 发表于 2025-3-25 14:48:25

http://reply.papertrans.cn/71/7036/703513/703513_23.png

mortuary 发表于 2025-3-25 18:34:12

http://reply.papertrans.cn/71/7036/703513/703513_24.png

Ligneous 发表于 2025-3-25 22:06:27

Toxicology of Biguanidese, phenylethylbiguanide (phenformin), was given marketing approval in the United States in 1957. Due to the serious side effects, however, the compound was withdrawn from the market in the United States and the major European countries about 20 years later. Similar problems occurred with .-butylbigu

开头 发表于 2025-3-26 00:20:33

Clinical Pharmacology of Biguanides983; . 1992). Repeated reports of phenformin-associated lactic acidosis led to the withdrawal of this biguanide in the United States in 1977 and in most other countries. Buformin shared the same fate, but metformin escaped withdrawal, even if the use became more restricted. At the same time the Univ

ARY 发表于 2025-3-26 05:35:20

http://reply.papertrans.cn/71/7036/703513/703513_27.png

受人支配 发表于 2025-3-26 08:27:43

http://reply.papertrans.cn/71/7036/703513/703513_28.png

overhaul 发表于 2025-3-26 16:04:36

http://reply.papertrans.cn/71/7036/703513/703513_29.png

遭遇 发表于 2025-3-26 20:09:53

http://reply.papertrans.cn/71/7036/703513/703513_30.png
页: 1 2 [3] 4 5 6
查看完整版本: Titlebook: Oral Antidiabetics; Jochen Kuhlmann,Walter Puls Book 1996 Springer-Verlag Berlin Heidelberg 1996 Antidiabetics.Biguanides.Diabetes.Diabete